CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing prevalence of chronic diseases
4.1.2. Availability of government and private funding for R&D
4.1.3. Rapid growth in ageing population
4.1.4. The high increase in disposable income
4.2. Market Restraints & Challenges
4.2.1. Increasing awareness towards animal depletion
4.2.2. Availability of alternate biomaterials
4.3. Market Opportunities
4.3.1. Growing research on collagen and gelatin-based products
4.3.2. Rise in awareness in emerging countries
CHAPTER 5. GLOBAL COLLAGEN & GELATIN MARKET FOR REGENERATIVE
MEDICINE – BY SOURCE
5.1. Introduction
5.2. Bovine collagen
5.3. Porcine collagen
5.4. Marine collagen
5.5. Other sources
CHAPTER 6. GLOBAL COLLAGEN & GELATIN MARKET FOR REGENERATIVE
MEDICINE – BY APPLICATION
6.1. Introduction
6.2. Orthopaedic applications
6.3. Wound care
6.4. Cardiovascular applications
6.5. Thoracic applications
6.6. Other applications
CHAPTER 7. GLOBAL COLLAGEN & GELATIN MARKET FOR REGENERATIVE
MEDICINE - BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL COLLAGEN & GELATIN MARKET FOR REGENERATIVE
MEDICINE - COMPANY PROFILES
8.1.Collagen Solutions Plc
8.2. Gelita AG.
8.3. Nitta Gelatin Inc.
8.4. Tessenderlo Group.
8.5. Symatese.
8.6. Vornia Biomaterials.
8.7. Advanced Biomatrix, Inc.
8.8. Royal DSM.
8.9. Jellagen Pty Ltd
8.10. EnColl Corporation.
8.11. XIAMEN HYFINE GELATIN CO., LTD.
8.12. Nucollagen, LLC
8.13. PB Gelatin
8.14. Collagen Matrix, Inc.
8.15. Integra Lifesciences Holdings Corporation
CHAPTER 9. GLOBAL COLLAGEN & GELATIN MARKET FOR REGENERATIVE
MEDICINE – COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
